Baldwin Wealth Partners LLC MA Sells 141,836 Shares of The Cooper Companies, Inc. $COO

Baldwin Wealth Partners LLC MA trimmed its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 84.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 25,555 shares of the medical device company’s stock after selling 141,836 shares during the quarter. Baldwin Wealth Partners LLC MA’s holdings in Cooper Companies were worth $1,752,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Buckhead Capital Management LLC raised its holdings in shares of Cooper Companies by 14.3% during the third quarter. Buckhead Capital Management LLC now owns 58,930 shares of the medical device company’s stock valued at $4,040,000 after purchasing an additional 7,368 shares during the last quarter. Amundi increased its position in Cooper Companies by 35.5% during the second quarter. Amundi now owns 1,331,480 shares of the medical device company’s stock valued at $97,225,000 after acquiring an additional 348,652 shares during the last quarter. Janney Montgomery Scott LLC boosted its position in Cooper Companies by 5.1% in the second quarter. Janney Montgomery Scott LLC now owns 97,394 shares of the medical device company’s stock worth $6,931,000 after purchasing an additional 4,761 shares during the last quarter. United Services Automobile Association purchased a new stake in shares of Cooper Companies during the 1st quarter valued at about $414,000. Finally, Westwood Holdings Group Inc. lifted its stake in shares of Cooper Companies by 23.4% in the 2nd quarter. Westwood Holdings Group Inc. now owns 311,745 shares of the medical device company’s stock worth $22,184,000 after purchasing an additional 59,190 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Up 0.4%

COO opened at $82.75 on Monday. The company has a market capitalization of $16.22 billion, a PE ratio of 44.02, a price-to-earnings-growth ratio of 2.36 and a beta of 1.05. The firm has a 50-day simple moving average of $74.70 and a two-hundred day simple moving average of $72.06. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30. The Cooper Companies, Inc. has a 52 week low of $61.78 and a 52 week high of $100.24.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, December 4th. The medical device company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. The company had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the previous year, the business earned $1.04 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies declared that its board has approved a stock buyback program on Wednesday, September 17th that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the medical device company to buy up to 15.4% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s management believes its stock is undervalued.

Insider Transactions at Cooper Companies

In other Cooper Companies news, Director Lawrence Erik Kurzius bought 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 17th. The stock was purchased at an average cost of $82.50 per share, with a total value of $165,000.00. Following the completion of the acquisition, the director owned 7,777 shares in the company, valued at $641,602.50. This trade represents a 34.62% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Maria Rivas purchased 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 18th. The shares were acquired at an average cost of $82.13 per share, for a total transaction of $82,130.00. Following the purchase, the director owned 11,141 shares of the company’s stock, valued at $915,010.33. This represents a 9.86% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have bought a total of 16,230 shares of company stock valued at $1,291,233 over the last quarter. 1.98% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research firms have weighed in on COO. Citigroup reiterated a “neutral” rating and issued a $88.00 price target (up from $72.00) on shares of Cooper Companies in a research report on Monday, December 8th. Morgan Stanley boosted their price target on Cooper Companies from $76.00 to $83.00 and gave the company an “equal weight” rating in a report on Monday, December 8th. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $71.00 price objective (up previously from $64.00) on shares of Cooper Companies in a research note on Monday, December 8th. Wells Fargo & Company boosted their price objective on Cooper Companies from $72.00 to $82.00 and gave the company an “equal weight” rating in a research note on Friday, December 5th. Finally, Barclays reaffirmed an “overweight” rating and set a $91.00 price target on shares of Cooper Companies in a report on Monday, December 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Cooper Companies currently has an average rating of “Moderate Buy” and an average target price of $90.15.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.